These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27481444)

  • 21. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade.
    Hirsch HJ; Eldar-Geva T; Bennaroch F; Pollak Y; Gross-Tsur V
    Hum Reprod; 2015 Nov; 30(11):2587-96. PubMed ID: 26345685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of Prader-Willi syndrome on the family's quality of life and caregiving, and the unaffected siblings' psychosocial adjustment.
    Mazaheri MM; Rae-Seebach RD; Preston HE; Schmidt M; Kountz-Edwards S; Field N; Cassidy S; Packman W
    J Intellect Disabil Res; 2013 Sep; 57(9):861-73. PubMed ID: 23057501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials.
    Luo Y; Zheng Z; Yang Y; Bai X; Yang H; Zhu H; Pan H; Chen S
    Endocrine; 2021 Feb; 71(2):321-330. PubMed ID: 33222122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TPH2 G/T polymorphism is associated with hyperphagia, IQ, and internalizing problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Bittel D; Butler MG
    J Child Psychol Psychiatry; 2011 May; 52(5):580-7. PubMed ID: 21418060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement.
    Myers SE; Davis A; Whitman BY; Santiago JV; Landt M
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):101-5. PubMed ID: 10651760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal trajectories of intellectual and adaptive functioning in adolescents and adults with Williams syndrome.
    Fisher MH; Lense MD; Dykens EM
    J Intellect Disabil Res; 2016 Oct; 60(10):920-32. PubMed ID: 27273269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.
    Dudley O; McManus B; Vogels A; Whittington J; Muscatelli F
    J Intellect Disabil Res; 2008 May; 52(Pt 5):426-36. PubMed ID: 18298478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
    Donze SH; Damen L; Mahabier EF; Hokken-Koelega ACS
    Eur J Endocrinol; 2020 Apr; 182(4):405-411. PubMed ID: 31961800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive profile in a large French cohort of adults with Prader-Willi syndrome: differences between genotypes.
    Copet P; Jauregi J; Laurier V; Ehlinger V; Arnaud C; Cobo AM; Molinas C; Tauber M; Thuilleaux D
    J Intellect Disabil Res; 2010 Mar; 54(3):204-15. PubMed ID: 20136683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
    Strong TV; Miller JL; McCandless SE; Gevers E; Yanovski JA; Matesevac L; Bohonowych J; Ballal S; Yen K; Hirano P; Cowen NM; Bhatnagar A
    J Neurodev Disord; 2024 Apr; 16(1):22. PubMed ID: 38671361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Academic underachievement by people with Prader-Willi syndrome.
    Whittington J; Holland A; Webb T; Butler J; Clarke D; Boer H
    J Intellect Disabil Res; 2004 Feb; 48(Pt 2):188-200. PubMed ID: 14723660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between cognitive performance and the rehabilitation, medical care and social support provided to French children with Prader-Willi syndrome.
    Roux-Levy PH; Bournez M; Masurel A; Jean N; Chancenotte S; Bordes M; Debomy F; Minot D; Schmitt E; Vinault S; Gautier E; Lacombe D; Odent S; Mikaty M; Manouvrier S; Ghoumid J; Geneviève D; Lehman N; Philip N; Edery P; Cornaton J; Gallard J; Héron D; Rastel C; Huet F; Thauvin-Robinet C; Verloes A; Binquet C; Tauber M; Lejeune C; Faivre L
    Eur J Med Genet; 2020 Dec; 63(12):104064. PubMed ID: 32998064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
    Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
    Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
    Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome.
    Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH
    Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study.
    Lo ST; Siemensma EP; Festen DA; Collin PJ; Hokken-Koelega AC
    Eur Child Adolesc Psychiatry; 2015 Sep; 24(9):1091-101. PubMed ID: 25522840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.